adult intensive & critical care; adult neurology; epidemiology; Critical Care/methods; Cross-Sectional Studies; Humans; Multicenter Studies as Topic; Registries; Retrospective Studies; Status Epilepticus/epidemiology; Status Epilepticus/therapy; Critical Care; Status Epilepticus; Medicine (all); General Medicine
Abstract :
[en] ("[en] INTRODUCTION: Status epilepticus (SE) is a common life-threatening neurological emergency that can cause long-term impairments. Overall outcomes remain poor. Major efforts are required to clarify the epidemiology of SE and the determinants of outcomes, thereby identifying targets for improved management.
METHODS AND ANALYSIS: ICTAL Registry is a multicentre open cohort of critically ill patients with convulsive, non-convulsive or psychogenic non-epileptic SE. Observational methods are applied to collect uniform data. The goal of the ICTAL Registry is to collect high-quality information on a large number of patients, thereby allowing elucidation of the pathophysiological mechanisms involved in mortality and morbidity. The registry structure is modular, with a large core data set and the opportunity for research teams to create satellite data sets for observational or interventional studies (eg, cohort multiple randomised controlled trials, cross-sectional studies and short-term and long-term longitudinal outcome studies). The availability of core data will hasten patient recruitment to studies, while also decreasing costs. Importantly, the vast amount of data from a large number of patients will allow valid subgroup analyses, which are expected to identify patient populations requiring specific treatment strategies. The results of the studies will have a broad spectrum of application, particularly given the multidisciplinary approach used by the IctalGroup research network.
ETHICS AND DISSEMINATION: The ICTAL Registry protocol was approved by the ethics committee of the French Intensive Care Society (#CE_SRLF 19-68 and 19-68a). Patients or their relatives/proxies received written information to the use of the retrospectively collected and pseudonymised data, in compliance with French law. Prospectively included patients receive written consent form as soon as they recover decision-making competency; if they refuse consent, they are excluded from the registry. Data from the registry will be disseminated via conference presentations and peer-reviewed publications.
TRIAL REGISTRATION NUMBER: NCT03457831.","[en] ","")
Disciplines :
Anesthesia & intensive care
Author, co-author :
Jacq, Gwenaelle; Service de réanimation et unité de soins continus, Centre Hospitalier de Versailles, Le Chesnay, France
Chelly, Jonathan ; Service de réanimation, Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, France
Quenot, Jean-Pierre ; Réanimation médicale, CHU Dijon, Dijon, France
Soulier, Pauline; Service de réanimation, Groupe Hospitalier Sud Ile-de-France, Melun, France
Lesieur, Olivier; Service de réanimation, Centre hospitalier de la Rochelle, La Rochelle, Nouvelle-Aquitaine, France
Beuret, Pascal; Service de Réanimation et Soins Continus, Centre Hospitalier de Roanne, Roanne, Rhône-Alpes, France
Holleville, Mathilde; Department of Anesthesiology and Critical Care, AP-HP, Paris, Nord, France
Bruel, Cedric; Service de réanimation, Groupe hospitalier Paris Saint Joseph, Paris, France
Bailly, Pierre ; Médecine Intensive Réanimation, CHU de Brest, Brest, France
Sauneuf, Bertrand; Service de réanimation, Centre Hospitalier Louis Pasteur de Cherbourg, Cherbourg-Octeville, Basse-Normandie, France
Sejourne, Caroline; Service de réanimation, Hôpital de Béthune, Beuvry, France
Rigaud, Jean Philippe; Service de réanimation, Centre Hospitalier de Dieppe, Dieppe, Haute-Normandie, France
Galbois, Arnaud; Intensive Care Unit, Claude Galien Private Hospital, Quincy-sous-Senart, Île-de-France, France
Arrayago, Marine; Department of Intensive Care, Cannes Hospital, Cannes, France
Plantefeve, Gaetan; Service de Médecine Intensive Réanimation, Centre Hospitalier d'Argenteuil, Argenteuil, Île-de-France, France
Stoclin, Annabelle; Service de réanimation, Instituy Gustave Roussy, Villejuif, France
Schnell, David; Service de réanimation, Hospital Centre Angouleme, Angouleme, Poitou-Charentes, France
Fontaine, Candice; Service de réanimation et unité de soins continus, Centre Hospitalier de Versailles, Le Chesnay, France
Perier, François; Service de réanimation et unité de soins continus, Centre Hospitalier de Versailles, Le Chesnay, France
Bougouin, Wulfran; Intensive Care Unit, Jacques Cartier Private Hospital, Massy, France
Pichon, Nicolas; Service de réanimation, Centre Hospitalier de Brive, Brive-la-Gaillarde, France
Mongardon, Nicolas; Service de Médecine Intensive-Réanimation, Hôpital Henri Mondor, Creteil, Île-de-France, France
Ledoux, Didier ; Centre Hospitalier Universitaire de Liège - CHU > > Service des soins intensifs
Lascarrou, Jean-Baptiste; Service de Médecine Intensive Réanimation, CHU Nantes, Nantes, Pays de la Loire, France
Legriel, Stephane ; Service de réanimation et unité de soins continus, Centre Hospitalier de Versailles, Le Chesnay, France slegriel@ch-versailles.fr ; University Paris-Saclay, UVSQ, INSERM, Team « PsyDev », CESP, Villejuif, France
Délégation à la Recherche Clinique et à l’Innovation (DRCI), Versailles, France
Funding text :
Acknowledgements We thank A Wolfe MD (Chaumont, France) for helping to prepare the manuscript. The study was supported by the French public funding agency Délégation à la Recherche Clinique et à l’Innovation (DRCI), Versailles, France.
Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56: 1515-23. doi:10.1111/epi.13121 http://www.ncbi.nlm.nih.gov/pubmed/26336950
Neligan A, Noyce AJ, Gosavi TD, et al. Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis. JAMA Neurol 2019; 76:897-905. doi:10.1001/jamaneurol.2019.1268 http://www.ncbi.nlm.nih.gov/pubmed/31135807
Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med 2008; 34: 476-80. doi:10.1007/s00134-007-0915-5 http://www.ncbi.nlm.nih.gov/pubmed/17965851
Legriel S, Azoulay E, Resche-Rigon M, et al. Functional outcome after convulsive status epilepticus. Crit Care Med 2010; 38: 2295-303. doi:10.1097/CCM.0b013e3181f859a6 http://www.ncbi.nlm.nih.gov/pubmed/20890201
Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-7. doi:10.1056/NEJMoa002141 http://www.ncbi.nlm.nih.gov/pubmed/11547716
Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs status epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792-8. doi:10.1056/NEJM199809173391202 http://www.ncbi.nlm.nih.gov/pubmed/9738086
Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 2019; 381: 2103-13. doi:10.1056/NEJMoa1905795 http://www.ncbi.nlm.nih.gov/pubmed/31774955
Asmussen S, Maybauer DM, Maybauer MO. Intramuscular versus intravenous benzodiazepines for status epilepticus. N Engl J Med 2012; 366: 1943-4. doi:10.1056/NEJMc1203428 http://www.ncbi.nlm.nih.gov/pubmed/22591304
Navarro V, Dagron C, Elie C, et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol 2016; 15: 47-55. doi:10.1016/S1474-4422(15)00296-3 http://www.ncbi.nlm.nih.gov/pubmed/26627366
Legriel S, Lemiale V, Schenck M, et al. Hypothermia for neuroprotection in convulsive status epilepticus. N Engl J Med 2016; 375: 2457-67. doi:10.1056/NEJMoa1608193 http://www.ncbi.nlm.nih.gov/pubmed/28002714
Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user's guide, 2014.
Maier S, Godau J, Bösel J, et al. Recognition and treatment of status epilepticus in the prehospital setting. Seizure 2021; 86: 1-5. doi:10.1016/j.seizure.2020.12.014 http://www.ncbi.nlm.nih.gov/pubmed/33485168
Gutiérrez-Viedma Álvaro, Parejo-Carbonell B, Romeral-Jiménez M, et al. Therapy delay in status epilepticus extends its duration and worsens its prognosis. Acta Neurol Scand 2021; 143: 281-9. doi:10.1111/ane.13363 http://www.ncbi.nlm.nih.gov/pubmed/33075155
Sathe AG, Underwood E, Coles LD, et al. Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial. Epilepsia 2021; 62: 795-806. doi:10.1111/epi.16825 http://www.ncbi.nlm.nih.gov/pubmed/33567109
Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016-26. doi:10.1016/S0140-6736(07)60461-9 http://www.ncbi.nlm.nih.gov/pubmed/17382828
Beuchat I, Novy J, Rossetti AO. Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents. CNS Drugs 2017; 31: 327-34. doi:10.1007/s40263-017-0424-1 http://www.ncbi.nlm.nih.gov/pubmed/28337727
Sánchez Fernández I, Gaínza-Lein M, Lamb N, et al. Meta-Analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology 2019; 92: e2339-48. doi:10.1212/WNL.0000000000007503 http://www.ncbi.nlm.nih.gov/pubmed/31068480
Guterman EL, Betjemann JP. Status epilepticus Mortality'Improving or status quo? JAMA Neurol 2019; 76:885. doi:10.1001/jamaneurol.2019.0844
Beniczky S, Hirsch LJ, Kaplan PW, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013; 54 Suppl 6: 28-9. doi:10.1111/epi.12270 http://www.ncbi.nlm.nih.gov/pubmed/24001066
Hirsch LJ, Fong MWK, Leitinger M, et al. American clinical neurophysiology Society's standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol 2021; 38: 1-29. doi:10.1097/WNP.0000000000000806 http://www.ncbi.nlm.nih.gov/pubmed/33475321
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23. doi:10.1007/s12028-012-9695-z http://www.ncbi.nlm.nih.gov/pubmed/22528274
Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012; 135: 2314-28. doi:10.1093/brain/aws091 http://www.ncbi.nlm.nih.gov/pubmed/22577217
Kanemoto K, LaFrance WC, Duncan R, et al. PNES around the world: where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task force report. Epilepsia Open 2017; 2: 307-16. doi:10.1002/epi4.12060 http://www.ncbi.nlm.nih.gov/pubmed/29588959
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the 'Utstein style'. Prepared by a Task Force of Representatives from the European Resuscitation Council, American Heart Association, Heart and Stroke Foundation of Canada, Australian Resuscitation Council. Resuscitation 1991; 22: 1-26. http://www.ncbi.nlm.nih.gov/pubmed/1658890
Outin H, Lefort H, Peigne V, et al. Guidelines for the management of status epilepticus. Eur J Emerg Med 2021; 28: 420-2. doi:10.1097/MEJ.0000000000000857 http://www.ncbi.nlm.nih.gov/pubmed/34334768
Wu K, Hirsch LJ, Babl FE, et al. Choosing anticonvulsant medications to manage status epilepticus. N Engl J Med 2020; 382: 2569-72. doi:10.1056/NEJMclde2004317 http://www.ncbi.nlm.nih.gov/pubmed/32579819
Legriel S, Oddo M, Brophy GM. What's new in refractory status epilepticus? Intensive Care Med 2017; 43: 543-6. doi:10.1007/s00134-016-4501-6 http://www.ncbi.nlm.nih.gov/pubmed/27544138
Katz JB, Owusu K, Nussbaum I, et al. Pearls and pitfalls of introducing ketogenic diet in adult status epilepticus: a practical guide for the intensivist. J Clin Med 2021; 10. doi: doi:10.3390/jcm10040881. [Epub ahead of print: 22 02 2021]. http://www.ncbi.nlm.nih.gov/pubmed/33671485
De Stefano P, Baumann SM, Semmlack S, et al. Safety and efficacy of coma induction following first-line treatment in status epilepticus: a 2-Center study. Neurology 2021; 97: e564-76. doi:10.1212/WNL.0000000000012292 http://www.ncbi.nlm.nih.gov/pubmed/34045273
Zeidan S, Rohaut B, Outin H, et al. Not all patients with convulsive status epilepticus intubated in pre-hospital settings meet the criteria for refractory status epilepticus. Seizure 2021; 88: 29-35. doi:10.1016/j.seizure.2021.03.015 http://www.ncbi.nlm.nih.gov/pubmed/33799137
Fontaine C, Lemiale V, Resche-Rigon M, et al. Association of systemic secondary brain insults and outcome in patients with convulsive status epilepticus: a post hoc study of a randomized controlled trial. Neurology 2020; 95: e2529-41. doi:10.1212/WNL.0000000000010726 http://www.ncbi.nlm.nih.gov/pubmed/32913029
Claassen J, Taccone FS, Horn P, et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med 2013; 39: 1337-51. doi:10.1007/s00134-013-2938-4 http://www.ncbi.nlm.nih.gov/pubmed/23653183
Fung FW, Abend NS. Eeg monitoring after convulsive status epilepticus. J Clin Neurophysiol 2020; 37: 406-10. doi:10.1097/WNP.0000000000000664 http://www.ncbi.nlm.nih.gov/pubmed/32890062
Limotai C, Ingsathit A, Thadanipon K, et al. How and whom to monitor for seizures in an ICU: a systematic review and meta-analysis. Crit Care Med 2019; 47: e366-73. doi:10.1097/CCM.0000000000003641 http://www.ncbi.nlm.nih.gov/pubmed/30855328
Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol 2015; 32: 87-95. doi:10.1097/WNP.0000000000000166 http://www.ncbi.nlm.nih.gov/pubmed/25626778
